NeurologyLive® Staff

Considerations that affect recommendations for novel oral treatment for relapsing-remitting multiple sclerosis vs a more conventional option.

Best practices for talking about treatment goals and options with patients who have relapsing-remitting multiple sclerosis.

Here's what is coming soon to NeurologyLive®.

Neurology News Network for the week ending November 27, 2021.

Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending November 26, 2021.

The rationale for early treatment initiation for patients with relapsing-remitting multiple sclerosis.

The patient symptoms that help neurologists distinguish relapsing and remitting multiple sclerosis from other forms of the disease, and recommendations regarding the best timing to initiate therapy.

Here's what is coming soon to NeurologyLive®.

Neurology News Network for the week ending November 20, 2021.

Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending November 19, 2021.

Chaired by Jennifer Graves, MD, PhD, MAS, the presentations also feature UC San Diego Health experts Jenelle Raynowska, MD; Jennifer Yang, MD; and Anastasie Dunn-Pirio, MD. [WATCH TIME: 1 hour, 23 minutes]

Here's what is coming soon to NeurologyLive.

Neurology News Network for the week ending November 13, 2021.

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending November 12, 2021.

Here's what is coming soon to NeurologyLive.

Neurology News Network for the week ending November 6, 2021.

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending November 5, 2021.

Robert Fox, MD, discussed what’s currently available in terms of cannabis-derived medications that treat symptoms of multiple sclerosis, and realistic possibility of another soon entering the market.

Research on advanced therapies and immune systems have helped clinicians understand more about how to improve treatments for multiple sclerosis.

Here's what is coming soon to NeurologyLive.

Neurology News Network for the week ending October 30, 2021.

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending October 29, 2021.

Here's what is coming soon to NeurologyLive.

Neurology News Network for the week ending October 23, 2021. [WATCH TIME: 3 minutes]

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending October 22, 2021.

Chaired by Devon Conway, MD, the presentations also feature Cleveland Clinic experts Kedar Mahajan, MD, PhD; Marisa McGinley, DO; and Amy Kunchok, MD. [WATCH TIME: 1 hour, 33 minutes]

Dr Brian G. Weinshenker envisions the future management of neuromyelitis optica spectrum disorders based on his involvement in research programs and treatment advances occurring in neurology.

Patients with neuromyelitis optica spectrum disorders highlight the types of resources and support that have helped them manage their neurological condition.

Jacinta M. Behne, MA, of the Guthy-Jackson Charitable Foundation, reacts to the types of research programs the organization has been involved in, regarding better treatments for patients with neuromyelitis optica spectrum disorders.

Here's what is coming soon to NeurologyLive.